NO20054258L - Subkutant avleveringssystem, fremgangsmate for fremstilling derav og anvendese av samme for behandling av kolinerg svikt lidelser - Google Patents
Subkutant avleveringssystem, fremgangsmate for fremstilling derav og anvendese av samme for behandling av kolinerg svikt lidelserInfo
- Publication number
- NO20054258L NO20054258L NO20054258A NO20054258A NO20054258L NO 20054258 L NO20054258 L NO 20054258L NO 20054258 A NO20054258 A NO 20054258A NO 20054258 A NO20054258 A NO 20054258A NO 20054258 L NO20054258 L NO 20054258L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- delivery system
- group
- cholinergic
- treatment
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 230000001713 cholinergic effect Effects 0.000 title 1
- 238000007920 subcutaneous administration Methods 0.000 title 1
- 239000011159 matrix material Substances 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000012377 drug delivery Methods 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
- Percussion Or Vibration Massage (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB0300942 | 2003-03-14 | ||
| IB0304945 | 2003-11-05 | ||
| PCT/IB2004/000734 WO2004080436A1 (en) | 2003-03-14 | 2004-03-15 | Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20054258D0 NO20054258D0 (no) | 2005-09-15 |
| NO20054258L true NO20054258L (no) | 2005-11-24 |
Family
ID=32992641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20054258A NO20054258L (no) | 2003-03-14 | 2005-09-15 | Subkutant avleveringssystem, fremgangsmate for fremstilling derav og anvendese av samme for behandling av kolinerg svikt lidelser |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20070059369A1 (https=) |
| EP (2) | EP1603532B1 (https=) |
| JP (1) | JP2006520378A (https=) |
| KR (1) | KR20060023111A (https=) |
| AT (1) | ATE404170T1 (https=) |
| AU (1) | AU2004218896B2 (https=) |
| BR (1) | BRPI0407818A (https=) |
| CA (1) | CA2518883A1 (https=) |
| CY (1) | CY1108482T1 (https=) |
| DE (1) | DE602004015744D1 (https=) |
| DK (1) | DK1603532T3 (https=) |
| EA (1) | EA011169B1 (https=) |
| ES (1) | ES2312981T3 (https=) |
| IL (1) | IL170759A (https=) |
| IS (1) | IS8067A (https=) |
| MX (1) | MXPA05009626A (https=) |
| NO (1) | NO20054258L (https=) |
| NZ (1) | NZ542459A (https=) |
| PL (1) | PL1603532T3 (https=) |
| PT (1) | PT1603532E (https=) |
| SI (1) | SI1603532T1 (https=) |
| UA (1) | UA82226C2 (https=) |
| WO (1) | WO2004080436A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1781264E (pt) | 2004-08-04 | 2013-10-16 | Evonik Corp | Métodos para o fabrico de dispositivis de administração e dispositivos para a mesma |
| US8124601B2 (en) * | 2007-11-21 | 2012-02-28 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
| ES2718612T3 (es) | 2007-12-20 | 2019-07-03 | Evonik Corp | Procedimiento para preparar micropartículas que tienen un bajo volumen de disolvente residual |
| US8956636B2 (en) * | 2008-04-18 | 2015-02-17 | Warsaw Orthopedic, Inc. | Methods and compositions for treating postoperative pain comprosing ketorolac |
| WO2011132157A1 (en) | 2010-04-22 | 2011-10-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Oral sustained release formulation of huperzine a |
| WO2013173096A2 (en) * | 2012-05-18 | 2013-11-21 | Insero Health Inc. | Conjugates of huperzine and analogs thereof |
| KR101811797B1 (ko) * | 2013-04-03 | 2017-12-22 | 동국제약 주식회사 | 도네페질을 포함하는 비경구투여용 약제학적 조성물 |
| WO2019078233A1 (ja) * | 2017-10-19 | 2019-04-25 | 株式会社佐藤園 | 学習記憶能力増強組成物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5106979A (en) * | 1989-02-21 | 1992-04-21 | University Of Pittsburgh | Method for the synthesis of huperzine A and analogs thereof and compounds useful therein |
| CN1125725A (zh) * | 1994-12-28 | 1996-07-03 | 中国科学院上海药物研究所 | 一类海克林碱衍生物及它的用途 |
| FR2756493B1 (fr) * | 1996-12-02 | 2001-04-13 | Delab | Dispositif d'administration locale de formulations solides ou semi-solides |
| US6352715B1 (en) | 1998-02-19 | 2002-03-05 | Sagittarius Life Science Corp | Transdermal rate-controlled delivery of Huperzine A for treatment of alzheimer's disease |
| US6565874B1 (en) * | 1998-10-28 | 2003-05-20 | Atrix Laboratories | Polymeric delivery formulations of leuprolide with improved efficacy |
| CN1279065A (zh) | 1999-07-06 | 2001-01-10 | 青岛科达生物工程有限公司 | 一种治疗记忆障碍和老年痴呆的药物组合物 |
| CN1194688C (zh) * | 2001-07-03 | 2005-03-30 | 山东绿叶制药股份有限公司 | 石杉碱甲及其衍生物或其盐的注射用缓释微球及其制备方法 |
| CN1383824A (zh) | 2002-05-21 | 2002-12-11 | 浙江省医学科学院 | 石杉碱鼻腔给药制剂 |
-
2004
- 2004-03-15 BR BRPI0407818-7A patent/BRPI0407818A/pt not_active IP Right Cessation
- 2004-03-15 CA CA002518883A patent/CA2518883A1/en not_active Abandoned
- 2004-03-15 DE DE602004015744T patent/DE602004015744D1/de not_active Expired - Lifetime
- 2004-03-15 ES ES04720662T patent/ES2312981T3/es not_active Expired - Lifetime
- 2004-03-15 MX MXPA05009626A patent/MXPA05009626A/es active IP Right Grant
- 2004-03-15 UA UAA200509681A patent/UA82226C2/uk unknown
- 2004-03-15 DK DK04720662T patent/DK1603532T3/da active
- 2004-03-15 SI SI200430920T patent/SI1603532T1/sl unknown
- 2004-03-15 AU AU2004218896A patent/AU2004218896B2/en not_active Ceased
- 2004-03-15 EP EP04720662A patent/EP1603532B1/en not_active Expired - Lifetime
- 2004-03-15 PT PT04720662T patent/PT1603532E/pt unknown
- 2004-03-15 NZ NZ542459A patent/NZ542459A/en unknown
- 2004-03-15 PL PL04720662T patent/PL1603532T3/pl unknown
- 2004-03-15 US US10/549,167 patent/US20070059369A1/en not_active Abandoned
- 2004-03-15 EP EP08159962A patent/EP1977735A1/en not_active Withdrawn
- 2004-03-15 EA EA200501433A patent/EA011169B1/ru not_active IP Right Cessation
- 2004-03-15 JP JP2006506340A patent/JP2006520378A/ja active Pending
- 2004-03-15 AT AT04720662T patent/ATE404170T1/de not_active IP Right Cessation
- 2004-03-15 WO PCT/IB2004/000734 patent/WO2004080436A1/en not_active Ceased
- 2004-03-15 KR KR1020057016999A patent/KR20060023111A/ko not_active Ceased
-
2005
- 2005-09-08 IL IL170759A patent/IL170759A/en not_active IP Right Cessation
- 2005-09-15 NO NO20054258A patent/NO20054258L/no not_active Application Discontinuation
- 2005-10-11 IS IS8067A patent/IS8067A/is unknown
-
2008
- 2008-11-06 CY CY20081101257T patent/CY1108482T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20070059369A1 (en) | 2007-03-15 |
| PT1603532E (pt) | 2008-11-20 |
| EP1603532A1 (en) | 2005-12-14 |
| NO20054258D0 (no) | 2005-09-15 |
| MXPA05009626A (es) | 2005-10-18 |
| EP1977735A1 (en) | 2008-10-08 |
| WO2004080436A1 (en) | 2004-09-23 |
| NZ542459A (en) | 2008-12-24 |
| SI1603532T1 (sl) | 2009-02-28 |
| BRPI0407818A (pt) | 2006-02-14 |
| JP2006520378A (ja) | 2006-09-07 |
| AU2004218896A1 (en) | 2004-09-23 |
| ATE404170T1 (de) | 2008-08-15 |
| HK1089085A1 (zh) | 2006-11-24 |
| PL1603532T3 (pl) | 2009-02-27 |
| KR20060023111A (ko) | 2006-03-13 |
| IL170759A (en) | 2010-06-16 |
| DK1603532T3 (da) | 2008-12-08 |
| CY1108482T1 (el) | 2014-04-09 |
| EA200501433A1 (ru) | 2006-02-24 |
| UA82226C2 (uk) | 2008-03-25 |
| ES2312981T3 (es) | 2009-03-01 |
| AU2004218896B2 (en) | 2010-04-01 |
| EP1603532B1 (en) | 2008-08-13 |
| EA011169B1 (ru) | 2009-02-27 |
| IS8067A (is) | 2005-10-11 |
| CA2518883A1 (en) | 2004-09-23 |
| DE602004015744D1 (de) | 2008-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108482T1 (el) | Συστημα υποδοριας διανομης, μεθοδος παρασκευης του και χρηση του για την αγωγη διαταραχων xολινεργικης ανεπαρκειας | |
| CY1107452T1 (el) | Διαδερμικη μορφη χορηγησης για τη θεραπεια του συνδρομου ανησυχων ποδιων | |
| YU75903A (sh) | Tiohidantoini i njihovo korišćenje u lečenju dijabetisa | |
| TW200615266A (en) | Organic compounds | |
| ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
| CY1115289T1 (el) | Μεθοδοι αγωγης εναντι ασθενειας που σχετιζεται με φλεγμονη | |
| BR0116370A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente. | |
| BR0315580A (pt) | Derivados de metileno uréia | |
| MY142551A (en) | Substituted diaryl heterocycles, process for their preparation and their use as medicaments | |
| BR0212078A (pt) | Método de tratar ou prevenir uma doença relacionada com amilóide em um paciente, composição farmacêutica, composto quìmico, e, uso de um composto | |
| UA85708C2 (ru) | Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей | |
| AR020662A1 (es) | Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento. | |
| BR0211305A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças ou condições e uso de um composto | |
| DE60305484D1 (de) | Verbindungen und deren verwendung als 5-ht inhibitore | |
| NO20020282D0 (no) | Nytt difenylpiperidinderivat | |
| AR001790A1 (es) | Formulaciones para parches transdermicos que sirven para el tratamiento de condiciones modeladas de receptores muscarinicos | |
| ATE252389T1 (de) | Ein arzneimittel zur behandlung von fettleibigkeit und verbesserung des lipidmetabolismus | |
| NO20041060L (no) | Krystaller av hydroksynorefedrinderivat | |
| GB2446341A (en) | Method and system for transdermal drug delivery | |
| ID29025A (id) | Fenilalkenoilguanidina-fenilalkenoilguanidina yang disubstitusi asam empedu, proses pembuatannya, penggunaannya sebagai obat atau diaknostik dan obat-obat yang mengandungnya | |
| DK1534352T3 (da) | Implantat til transport og afgivelse af farmakologisk aktive midler såvel som en fremgangsmåde til fremstilling af samme | |
| BR0111897A (pt) | Composto, método para tratar um indivìduo afligido por alguns distúrbios dos sistemas nervosos periférico e central, composição farmacêutica, e, uso de um composto | |
| WO2005056520A8 (en) | Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy | |
| BR0014447A (pt) | Derivados de piperidina como inibidores da reabsorção | |
| TW200503714A (en) | Pde9 inhibitors for treating type 2 diabetes, metabolic syndrome, and cardiovascular disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |